Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chubb
Argus Health
US Department of Justice
Fish and Richardson
Federal Trade Commission

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 8,258,308

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,258,308
Title:Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors
Abstract: The present disclosure relates to compounds of formula (I): ##STR00001## or a pharmaceutically acceptable salt or N-oxide thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds of formula (I), and to their methods of use in therapy.
Inventor(s): Castro Palomino Laria; Julio Cesar (Barcelona, ES), Erra Sola; Montserrat (Barcelona, ES), Lozoya Toribio; Maria Estrella (Barcelona, ES), Navarro Romero; Eloisa (Barcelona, ES)
Assignee: Laboratorios Almirall, S.A. (Barcelona, ES)
Application Number:12/520,237
Patent Claims:see list of patent claims

Details for Patent 8,258,308

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Janssen Biotech SIMPONI ARIA golimumab INJECTABLE; INJECTION 125433 001 2013-07-18 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Glaxo Grp Ltd ARZERRA ofatumumab INJECTABLE; INJECTION 125326 001 2009-10-26 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Centocor Ortho Biotech Inc SIMPONI golimumab INJECTABLE; INJECTION 125289 001 2009-04-24 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Ucb Inc CIMZIA certolizumab pegol INJECTABLE; INJECTION 125160 001 2008-04-22 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up Laboratorios Almirall, S.A. (Barcelona, ES) 2026-12-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Fuji
Mallinckrodt
McKesson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.